Aurinia Pharmaceuticals Inc (AUPH) stock forecast — our track record

Lyra published 10 AUPH stock forecasts for Aurinia Pharmaceuticals Inc, starting on July 11, 2025. Every prediction was released before its outcome was known. All 10 calls were later closed and scored. The full track record used one horizon, short term (0 to 3 months). The scoring windows ran through September 1, 2026, so these results covered completed calls with known outcomes.

Nine of the 10 targets were reached. None of the calls missed, while one received partial credit. The average success score was 92.5%, and the average peak gain was 27.7%. Since every forecast used the short-term horizon, its average score was also 92.5%. The results were therefore based entirely on calls made over the same forecast period.

The best call was published on July 11, 2025. It predicted growth of 38%, and the stock rose as much as 51.6%. The target was reached in 35 days, and the call received a 100% success score. The weakest call was published on November 4, 2025. It predicted growth of 22%, but the stock rose only 4.1% at its peak and did not reach the target. That call received a 50% score. Overall, the record was strong: nine targets were reached, there were no misses, and one call earned partial credit.